Lessons from the history of antipsychotic discovery: part 2 - dopaminergic diversification.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-10-08
DOI
https://doi.org/10.1192/bjb.2026.10266
Primary Topic
Historical Psychiatry and Medical Practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lessons from the history of antipsychotic discovery: part 2 - dopaminergic diversification.

Jérémy Hall
PubMed
Historical Psychiatry and Medical Practices
article

Lessons from the history of antipsychotic discovery: part 2 - dopaminergic diversification.

Jérémy Hall
article en

Abstract

No abstract available for this paper.
PubMed
University of Oxford (GB), Cardiff University (GB)
Openalex Percentile: Top 8%
Historical Psychiatry and Medical Practices
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lessons from the history of antipsychotic discovery: part 2 - dopaminergic diversification. — Jérémy Hall · PubMed (2026) | TGRS Research Map | TGRS